{"entity":{"type":"insider","cik":"0001448698","url":"/insider/0001448698","json_url":"/insider/0001448698.json","name":"Cherington Charles","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":27,"n_filings":15,"first":"2021-06-21","last":"2026-02-17","span_basis":"filed_date"},"name_variants":[{"name":"Cherington Charles","source":"filing","n_filings":15,"first_seen":"2021-06-21","last_seen":"2026-02-17"}],"transactions":[{"id":5903463,"accession":"0001104659-26-016680","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-016680","line_url":"/filing/0001104659-26-016680#line-1","is_derivative":false,"issuer_cik":"0000748592","issuer_name":"Ernexa Therapeutics Inc.","issuer_ticker":"ERNA","issuer_name_source":null,"issuer_url":"/issuer/0000748592","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000000.0,"shares_display":"4,000,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":2000000.0,"total_display":"2,000,000.00","total_whole":"2,000,000","shares_owned_after":6779440.0,"shares_owned_after_display":"6,779,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-10","filed_date":"2026-02-17","scope":"insider"},{"id":4955773,"accession":"0001104659-25-058644","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-058644","line_url":"/filing/0001104659-25-058644#line-1","is_derivative":false,"issuer_cik":"0000748592","issuer_name":"Ernexa Therapeutics Inc.","issuer_ticker":"ERNA","issuer_name_source":null,"issuer_url":"/issuer/0000748592","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21241163.0,"shares_display":"21,241,163","price_per_share":0.1046,"price_display":"0.10","price_state":"stated","total_value":2221825.6498,"total_display":"2,221,825.65","total_whole":"2,221,826","shares_owned_after":41659743.0,"shares_owned_after_display":"41,659,743","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-09","filed_date":"2025-06-11","scope":"insider"},{"id":4421892,"accession":"0001104659-25-032060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-032060","line_url":"/filing/0001104659-25-032060#line-1","is_derivative":false,"issuer_cik":"0000748592","issuer_name":"Eterna Therapeutics Inc.","issuer_ticker":"ERNA","issuer_name_source":null,"issuer_url":"/issuer/0000748592","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3768397.0,"shares_display":"3,768,397","price_per_share":0.1046,"price_display":"0.10","price_state":"stated","total_value":394174.3262,"total_display":"394,174.33","total_whole":"394,174","shares_owned_after":20401602.0,"shares_owned_after_display":"20,401,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-02","filed_date":"2025-04-04","scope":"insider"},{"id":2538367,"accession":"0001104659-24-114222","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-24-114222","line_url":"/filing/0001104659-24-114222#line-6","is_derivative":false,"issuer_cik":"0000748592","issuer_name":"Eterna Therapeutics Inc.","issuer_ticker":"ERNA","issuer_name_source":null,"issuer_url":"/issuer/0000748592","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5420823.0,"shares_display":"5,420,823","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":12245589.0,"shares_owned_after_display":"12,245,589","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-29","filed_date":"2024-11-05","scope":"insider"},{"id":2538363,"accession":"0001104659-24-114222","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-24-114222","line_url":"/filing/0001104659-24-114222#line-5","is_derivative":false,"issuer_cik":"0000748592","issuer_name":"Eterna Therapeutics Inc.","issuer_ticker":"ERNA","issuer_name_source":null,"issuer_url":"/issuer/0000748592","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4768783.0,"shares_display":"4,768,783","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":5587004.0,"shares_owned_after_display":"5,587,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-29","filed_date":"2024-11-05","scope":"insider"},{"id":2538360,"accession":"0001104659-24-114222","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-114222","line_url":"/filing/0001104659-24-114222#line-4","is_derivative":false,"issuer_cik":"0000748592","issuer_name":"Eterna Therapeutics Inc.","issuer_ticker":"ERNA","issuer_name_source":null,"issuer_url":"/issuer/0000748592","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1562988.0,"shares_display":"1,562,988","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":13808577.0,"shares_owned_after_display":"13,808,577","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-29","filed_date":"2024-11-05","scope":"insider"},{"id":2538358,"accession":"0001104659-24-114222","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-114222","line_url":"/filing/0001104659-24-114222#line-3","is_derivative":false,"issuer_cik":"0000748592","issuer_name":"Eterna Therapeutics Inc.","issuer_ticker":"ERNA","issuer_name_source":null,"issuer_url":"/issuer/0000748592","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1237762.0,"shares_display":"1,237,762","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":6824766.0,"shares_owned_after_display":"6,824,766","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-29","filed_date":"2024-11-05","scope":"insider"},{"id":2538354,"accession":"0001104659-24-114222","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-114222","line_url":"/filing/0001104659-24-114222#line-2","is_derivative":false,"issuer_cik":"0000748592","issuer_name":"Eterna Therapeutics Inc.","issuer_ticker":"ERNA","issuer_name_source":null,"issuer_url":"/issuer/0000748592","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":261756.0,"shares_display":"261,756","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":818221.0,"shares_owned_after_display":"818,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-29","filed_date":"2024-11-05","scope":"insider"},{"id":9223945,"accession":"0001104659-25-045416","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-25-045416","line_url":"/filing/0001104659-25-045416#line-5","is_derivative":false,"issuer_cik":"0001448698","issuer_name":"Ernexa Therapeutics Inc.","issuer_ticker":"ERNA","issuer_name_source":null,"issuer_url":"/issuer/0001448698","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1562988.0,"shares_display":"1,562,988","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":13808577.0,"shares_owned_after_display":"13,808,577","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-24","filed_date":"2025-05-07","scope":"insider"},{"id":9223944,"accession":"0001104659-25-045416","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-25-045416","line_url":"/filing/0001104659-25-045416#line-4","is_derivative":false,"issuer_cik":"0001448698","issuer_name":"Ernexa Therapeutics Inc.","issuer_ticker":"ERNA","issuer_name_source":null,"issuer_url":"/issuer/0001448698","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5420823.0,"shares_display":"5,420,823","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":12245589.0,"shares_owned_after_display":"12,245,589","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-24","filed_date":"2025-05-07","scope":"insider"},{"id":9223943,"accession":"0001104659-25-045416","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-25-045416","line_url":"/filing/0001104659-25-045416#line-3","is_derivative":false,"issuer_cik":"0001448698","issuer_name":"Ernexa Therapeutics Inc.","issuer_ticker":"ERNA","issuer_name_source":null,"issuer_url":"/issuer/0001448698","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1237762.0,"shares_display":"1,237,762","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":6824766.0,"shares_owned_after_display":"6,824,766","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-24","filed_date":"2025-05-07","scope":"insider"},{"id":9223942,"accession":"0001104659-25-045416","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-045416","line_url":"/filing/0001104659-25-045416#line-1","is_derivative":false,"issuer_cik":"0001448698","issuer_name":"Ernexa Therapeutics Inc.","issuer_ticker":"ERNA","issuer_name_source":null,"issuer_url":"/issuer/0001448698","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":261756.0,"shares_display":"261,756","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":818221.0,"shares_owned_after_display":"818,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-24","filed_date":"2025-05-07","scope":"insider"},{"id":9223941,"accession":"0001104659-25-045416","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-045416","line_url":"/filing/0001104659-25-045416#line-2","is_derivative":false,"issuer_cik":"0001448698","issuer_name":"Ernexa Therapeutics Inc.","issuer_ticker":"ERNA","issuer_name_source":null,"issuer_url":"/issuer/0001448698","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4768783.0,"shares_display":"4,768,783","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":5587004.0,"shares_owned_after_display":"5,587,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-24","filed_date":"2025-05-07","scope":"insider"},{"id":8522178,"accession":"0001104659-23-099800","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-099800","line_url":"/filing/0001104659-23-099800#line-1","is_derivative":false,"issuer_cik":"0001448698","issuer_name":"Comera Life Sciences Holdings, Inc.","issuer_ticker":"CMRA","issuer_name_source":null,"issuer_url":"/issuer/0001448698","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2053789.0,"shares_display":"2,053,789","price_per_share":0.5112,"price_display":"0.51","price_state":"stated","total_value":1049896.9368,"total_display":"1,049,896.94","total_whole":"1,049,897","shares_owned_after":5813650.0,"shares_owned_after_display":"5,813,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-11","filed_date":"2023-09-11","scope":"insider"},{"id":8473303,"accession":"0001104659-23-095433","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-095433","line_url":"/filing/0001104659-23-095433#line-1","is_derivative":false,"issuer_cik":"0001448698","issuer_name":"Comera Life Sciences Holdings, Inc.","issuer_ticker":"CMRA","issuer_name_source":null,"issuer_url":"/issuer/0001448698","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":880195.0,"shares_display":"880,195","price_per_share":0.5113,"price_display":"0.51","price_state":"stated","total_value":450043.7035,"total_display":"450,043.70","total_whole":"450,044","shares_owned_after":3759861.0,"shares_owned_after_display":"3,759,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-31","filed_date":"2023-08-25","scope":"insider"},{"id":7886189,"accession":"0000899243-23-001182","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-001182","line_url":"/filing/0000899243-23-001182#line-1","is_derivative":false,"issuer_cik":"0001448698","issuer_name":"Comera Life Sciences Holdings, Inc.","issuer_ticker":"CMRA","issuer_name_source":null,"issuer_url":"/issuer/0001448698","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":743243.0,"shares_display":"743,243","price_per_share":1.23,"price_display":"1.23","price_state":"stated","total_value":914188.89,"total_display":"914,188.89","total_whole":"914,189","shares_owned_after":2879666.0,"shares_owned_after_display":"2,879,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-06","scope":"insider"},{"id":6293324,"accession":"0001140361-22-044639","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-044639","line_url":"/filing/0001140361-22-044639#line-1","is_derivative":false,"issuer_cik":"0000748592","issuer_name":"Eterna Therapeutics Inc.","issuer_ticker":"ERNA","issuer_name_source":null,"issuer_url":"/issuer/0000748592","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":261756.0,"shares_display":"261,756","price_per_share":3.28,"price_display":"3.28","price_state":"stated","total_value":858559.68,"total_display":"858,559.68","total_whole":"858,560","shares_owned_after":556465.0,"shares_owned_after_display":"556,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-02","filed_date":"2022-12-06","scope":"insider"},{"id":6266813,"accession":"0001062993-22-021051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-021051","line_url":"/filing/0001062993-22-021051#line-2","is_derivative":false,"issuer_cik":"0001448698","issuer_name":"Comera Life Sciences Holdings, Inc.","issuer_ticker":"CMRA","issuer_name_source":null,"issuer_url":"/issuer/0001448698","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11691.0,"shares_display":"11,691","price_per_share":1.5937,"price_display":"1.59","price_state":"stated","total_value":18631.9467,"total_display":"18,631.95","total_whole":"18,632","shares_owned_after":649937.0,"shares_owned_after_display":"649,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-21","filed_date":"2022-10-24","scope":"insider"},{"id":6266810,"accession":"0001062993-22-021051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-021051","line_url":"/filing/0001062993-22-021051#line-1","is_derivative":false,"issuer_cik":"0001448698","issuer_name":"Comera Life Sciences Holdings, Inc.","issuer_ticker":"CMRA","issuer_name_source":null,"issuer_url":"/issuer/0001448698","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3316.0,"shares_display":"3,316","price_per_share":1.5224,"price_display":"1.52","price_state":"stated","total_value":5048.2784,"total_display":"5,048.28","total_whole":"5,048","shares_owned_after":638246.0,"shares_owned_after_display":"638,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-20","filed_date":"2022-10-24","scope":"insider"},{"id":6629513,"accession":"0001062993-22-020905","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-020905","line_url":"/filing/0001062993-22-020905#line-2","is_derivative":false,"issuer_cik":"0001448698","issuer_name":"Comera Life Sciences Holdings, Inc.","issuer_ticker":"CMRA","issuer_name_source":null,"issuer_url":"/issuer/0001448698","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15266.0,"shares_display":"15,266","price_per_share":1.6602,"price_display":"1.66","price_state":"stated","total_value":25344.6132,"total_display":"25,344.61","total_whole":"25,345","shares_owned_after":634930.0,"shares_owned_after_display":"634,930","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-17","filed_date":"2022-10-18","scope":"insider"},{"id":6629510,"accession":"0001062993-22-020905","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-020905","line_url":"/filing/0001062993-22-020905#line-1","is_derivative":false,"issuer_cik":"0001448698","issuer_name":"Comera Life Sciences Holdings, Inc.","issuer_ticker":"CMRA","issuer_name_source":null,"issuer_url":"/issuer/0001448698","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4253.0,"shares_display":"4,253","price_per_share":1.6042,"price_display":"1.60","price_state":"stated","total_value":6822.6626,"total_display":"6,822.66","total_whole":"6,823","shares_owned_after":619664.0,"shares_owned_after_display":"619,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-14","filed_date":"2022-10-18","scope":"insider"},{"id":6100743,"accession":"0001062993-22-020800","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-020800","line_url":"/filing/0001062993-22-020800#line-1","is_derivative":false,"issuer_cik":"0001448698","issuer_name":"Comera Life Sciences Holdings, Inc.","issuer_ticker":"CMRA","issuer_name_source":null,"issuer_url":"/issuer/0001448698","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10481.0,"shares_display":"10,481","price_per_share":1.6589,"price_display":"1.66","price_state":"stated","total_value":17386.9309,"total_display":"17,386.93","total_whole":"17,387","shares_owned_after":615411.0,"shares_owned_after_display":"615,411","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-13","filed_date":"2022-10-14","scope":"insider"},{"id":6266780,"accession":"0001062993-22-020096","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-020096","line_url":"/filing/0001062993-22-020096#line-1","is_derivative":false,"issuer_cik":"0001448698","issuer_name":"Comera Life Sciences Holdings, Inc.","issuer_ticker":"CMRA","issuer_name_source":null,"issuer_url":"/issuer/0001448698","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17900.0,"shares_display":"17,900","price_per_share":1.8702,"price_display":"1.87","price_state":"stated","total_value":33476.58,"total_display":"33,476.58","total_whole":"33,477","shares_owned_after":604930.0,"shares_owned_after_display":"604,930","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-29","filed_date":"2022-09-30","scope":"insider"},{"id":6453775,"accession":"0001062993-22-020051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-020051","line_url":"/filing/0001062993-22-020051#line-1","is_derivative":false,"issuer_cik":"0001448698","issuer_name":"Comera Life Sciences Holdings, Inc.","issuer_ticker":"CMRA","issuer_name_source":null,"issuer_url":"/issuer/0001448698","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":1.6851,"price_display":"1.69","price_state":"stated","total_value":20221.2,"total_display":"20,221.20","total_whole":"20,221","shares_owned_after":587030.0,"shares_owned_after_display":"587,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-27","filed_date":"2022-09-29","scope":"insider"},{"id":4963063,"accession":"0001140361-21-021772","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-21-021772","line_url":"/filing/0001140361-21-021772","is_derivative":false,"issuer_cik":"0000748592","issuer_name":"Brooklyn ImmunoTherapeutics, Inc.","issuer_ticker":"BTX","issuer_name_source":null,"issuer_url":"/issuer/0000748592","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":15.749039,"price_display":"15.75","price_state":"stated","total_value":3149807.8,"total_display":"3,149,807.80","total_whole":"3,149,808","shares_owned_after":5896101.0,"shares_owned_after_display":"5,896,101","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-17","filed_date":"2021-06-21","scope":"insider","n_lines":2},{"id":4963052,"accession":"0001140361-21-021772","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-21-021772","line_url":"/filing/0001140361-21-021772#line-1","is_derivative":false,"issuer_cik":"0000748592","issuer_name":"Brooklyn ImmunoTherapeutics, Inc.","issuer_ticker":"BTX","issuer_name_source":null,"issuer_url":"/issuer/0000748592","owner_cik":"0001448698","owner_name":"Cherington Charles","owner_display_name":"Cherington Charles","owner_url":"/insider/0001448698","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":15.7338,"price_display":"15.73","price_state":"stated","total_value":3146760.0,"total_display":"3,146,760.00","total_whole":"3,146,760","shares_owned_after":6094101.0,"shares_owned_after_display":"6,094,101","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-16","filed_date":"2021-06-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":27,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":24,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":27},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000748592","name":"Ernexa Therapeutics Inc.","url":"/issuer/0000748592","role":"Director, Ten percent owner","n_filings":7,"first_seen":"2021-06-21","last_seen":"2026-02-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001907685","name":"Comera Life Sciences Holdings, Inc.","url":"/issuer/0001907685","role":"Ten percent owner","n_filings":8,"first_seen":"2022-09-29","last_seen":"2023-09-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001448698","retrieved_at":"2026-08-24T00:37:04+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}